Pfizer files for U.S. authorization of its pill to treat COVID-19
Global News
Pfizer says that its COVID-19 treatment pill can help to significantly cut the risk of death or hospitalization in high-risk adults.
Pfizer Inc said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial.
Pfizer said it completed submission of its application for emergency use authorization (EUA) of the drug, Paxlovid, with the U.S. Food and Drug Administration, including data from the drugmaker’s clinical trial.
The oral drug could be promising new weapon in the fight against the pandemic, as it can be taken as an early at-home treatment to help prevent COVID-19 hopitalizations and deaths. It could also become a important tool in countries and areas with limited access to vaccines or low vaccination rates.
It is not immediately clear when U.S. regulators will rule on Pfizer’s application. Merck & Co Inc and Ridgeback Biotherapeutics, which are developing a competing pill, molnupiravir, completed their EUA submission on Oct. 11.
A panel of outside advisers to the FDA will meet to consider that application on Nov. 30, and it is expected to be available this year.
“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application, along with other regulatory agencies around the world,” Pfizer Chief Executive Albert Bourla said in a news release.
The New York-based drugmaker said it has begun the process of seeking authorization in several countries including the United Kingdom, Australia, New Zealand and South Korea, and plans further international submissions.
Pfizer said earlier on Tuesday it will allow generic manufacturers to supply its COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP).
The report was released by the Manitoba Government and General Employees' Union and is based on feedback from crews and other staff involved in the wildfire fight.
Opponents of coal mining in the eastern slopes of the Rocky Mountains have some sharp criticism for Alberta's UCP government after being told to resubmit their citizens petition.
Three children in Ontario have died from influenza A-related complications since the start of December, health officials said Monday.
The company that operates the Trans Mountain pipeline has paid a $196,000 fine for environmental lapses along its B.C. pipeline route in the aftermath of a massive Jan. 2024 storm.
Alberta's provincial government has announced the creation of three new all-season resort areas that it claims could generate thousands of jobs and billions in economic benefits.
Corb Lund says he's seeking the intervention as new coal mines could threaten land and water on the eastern slopes of the Rocky Mountains and affect the Prairies downstream.
Officers had recently captured four grizzly bears, but forensic results came back to confirm that none of the bears, an adult female and three young, were linked to the attack.
The research recommends occipital nerve blocks should be offered in emergency rooms to treat acute migraine attacks.
A federal vaccine advisory committee voted on Friday to end the longstanding recommendation that all U.S. babies get the hepatitis B vaccine on the day they’re born.
Darlene Hensch, who once struggled with unexplained infertility, is now expecting quadruplets and preparing for a high-risk delivery and life-changing journey.
Negotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving forward.
They've been married for 55 years, but for most of that time, something has been missing from Janet and Robert Cockwill's life, until their grandson made a remarkable discovery.
NDP interim leader Don Davies said the government's response to a commissioned report on the program was 'shockingly dismissive,' and the health minister has not committed to act.